Endoscopic full-thickness plication along with argon plasma coagulation for treatment of proton pump inhibitor dependent gastroesophageal reflux disease

被引:0
|
作者
Harwani, Yogesh [1 ]
Butala, Shreya [2 ]
More, Balaji [3 ,5 ]
Shukla, Varun [4 ]
Patel, Anand [4 ]
机构
[1] Nobel Gastro Hosp, Dept Gastroenterol, Ahmadabad 408409, Gujarat, India
[2] Sanjay Gandhi Post Grad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India
[3] Mahatma Gandhi Med Coll & Res Inst, Dept Pharmacol, Pondicherry 607402, India
[4] Noble Inst Gastroenterol, Dept Gastroenterol, Ahmadabad 380009, Gujrat, India
[5] Mahatma Gandhi Med Coll & Res Inst, Dept Pharmacol, Sri Balaji Vidyapeeth, Pondicherry Cuddalore Rd,ECR, Pondicherry 607402, India
来源
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY | 2024年 / 16卷 / 05期
关键词
Gastroesophageal reflux disease; Endoscopy; Quality of life; Endoscopic antireflux interventions; Retrospective data analysis; Gastroesophageal reflux disease symptom scores; Proton pump inhibitor; TRANSORAL INCISIONLESS FUNDOPLICATION; QUALITY-OF-LIFE; CHRONIC GERD; LAPAROSCOPIC FUNDOPLICATION; ANTIREFLUX MUCOSECTOMY; MULTICENTER; TRIAL; EFFICACY; OUTCOMES;
D O I
10.4253/wjge.v16.i5.250
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Most endoscopic anti-reflux interventions for gastroesophageal reflux disease (GERD) management are technically challenging to practice with inadequate data to support it utility. Therefore, this study was carried to evaluate the effectiveness and safety newer endoscopic full-thickness fundoplication (EFTP) device along with Argon Plasma Coagulation to treat individuals with GERD. AIM To evaluate the effectiveness and safety newer EFTP device along with Argon Plasma Coagulation to treat individuals with GERD. METHODS This study was a single-center comparative analysis conducted on patients treated at a Noble Institute of Gastroenterology, Ahmedabad, hospital between 2020 and 2022. The research aimed to retrospectively analyze patient data on GERD symptoms and proton pump inhibitor (PPI) dependence who underwent EFTP using the GERD-X system along with argon plasma coagulation (APC). The primary endpoint was the mean change in the total gastroesophageal reflux disease health-related quality of life (GERD-HRQL) score compared to the baseline measurement at the 3-month follow-up. Secondary endpoints encompassed enhancements in the overall GERD-HRQL score, improvements in GERD symptom scores at the 3 and changes in PPI usage at the 3 and 12-month time points. RESULTS In this study, patients most were in Hill Class II, and over half had ineffective esophageal motility. Following the EFTP procedure, there were significant improvements in heartburn and regurgitation scores, as well as GERD-HRQL scores (P < 0.001). PPI use significantly decreased, with 82.6% not needing PPIs or prokinetics at end of 1 year. No significant adverse events related to the procedures were observed in either group. CONCLUSION The EFTP along with APC procedure shows promise in addressing GERD symptoms and improving patients' quality of life, particularly for suitable candidates. Moreover, the application of a lone clip with APC yielded superior outcomes and exhibited greater cost-effectiveness.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] The Cost Effectiveness of Adjunctive Treatments for Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease
    Rosas, Ulysses S.
    Almario, Christopher V.
    Yu, Kyung-Sang
    Spiegel, Brennan M. R.
    CLINICAL DRUG INVESTIGATION, 2024, 44 (09) : 703 - 714
  • [42] Prospective Evaluation of Duodenogastroesophageal Reflux in Gastroesophageal Reflux Disease Patients Refractory to Proton Pump Inhibitor Therapy
    Kunsch, S.
    Neesse, A.
    Linhart, T.
    Nell, C.
    Gress, T. M.
    Ellenrieder, V.
    DIGESTION, 2012, 86 (04) : 315 - 322
  • [43] The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease
    Ogawa, Maiko
    Arihiro, Seiji
    Matsuhashi, Nobuyuki
    Joh, Takashi
    Higuchi, Kazuhide
    Iwakiri, Katsuhiko
    Kamiya, Takeshi
    Manabe, Noriaki
    Isshi, Kimio
    Nakada, Tatsuya
    Hokari, Atsushi
    Saruta, Masayuki
    Oshio, Atsushi
    Haruma, Ken
    Nakada, Koji
    ESOPHAGUS, 2021, 18 (02) : 398 - 406
  • [44] Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients
    Foocharoen, Chingching
    Kingkaew, Pritaporn
    Teerawattananon, Yot
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Manasirisuk, Witsarut
    Chaiyarit, Jitjira
    Sangchan, Apichat
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (10) : 2037 - 2046
  • [45] Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region
    Goh, Khean Lee
    Choi, Myung Gyu
    Hsu, Ping I.
    Chun, Hoon Jai
    Mahachai, Varocha
    Kachintorn, Udom
    Leelakusolvong, Somchai
    Kim, Nayoung
    Rani, Abdul Aziz
    Wong, Benjamin C. Y.
    Wu, Justin
    Chiu, Cheng Tang
    Shetty, Vikram
    Bocobo, Joseph C.
    Chan, Melchor M.
    Lin, Jaw-Town
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (03) : 355 - 366
  • [46] Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease
    Dal-Paz, K.
    Moraes-Filho, J. P.
    Navarro-Rodriguez, T.
    Eisig, J. N.
    Barbuti, R.
    Quigley, E. M. M.
    DISEASES OF THE ESOPHAGUS, 2012, 25 (02) : 107 - 113
  • [47] Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor
    Takeuchi, Toshihisa
    Takahashi, Yoshiaki
    Kawaguchi, Shinpei
    Ota, Kazuhiro
    Harada, Satoshi
    Kojima, Yuichi
    Sakamoto, Hiroki
    Kuramoto, Takanori
    Kojima, Keishi
    Sanomura, Makoto
    Hoshimoto, Masahiro
    Higashino, Takeshi
    Itabashi, Tsukasa
    Takada, Ko
    Sakaguchi, Masahiro
    Tominaga, Kazunari
    Kusano, Motoyasu
    Higuchi, Kazuhide
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (03) : 623 - 630
  • [48] Endoscopic radiofrequency Stretta therapy reduces proton pump inhibitor dependency and the need for anti-reflux surgery for refractory gastroesophageal reflux disease
    Joel, Abraham
    Konjengbam, Alakh
    Viswanath, Yirupaiahgari
    Kourounis, Georgios
    Hammond, Emily
    Frank, Helen
    Kuttuva, Shivani
    Mbarushimana, Simon
    Hidayat, Hena
    Thulasiraman, Srivishnu
    CLINICAL ENDOSCOPY, 2024, 57 (01) : 58 - 64
  • [49] Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure
    Strid, Hans
    Fjell, Andreas
    Simren, Magnus
    Bjornsson, Einar S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (02) : 137 - 142
  • [50] Respiratory response to proton pump inhibitor treatment in children with obstructive sleep apnea syndrome and gastroesophageal reflux disease
    Wasilewska, Jolanta
    Semeniuk, Janusz
    Cudowska, Beata
    Klukowski, Mark
    Debkowska, Katarzyna
    Kaczmarski, Maciej
    SLEEP MEDICINE, 2012, 13 (07) : 824 - 830